Nextblockbuster & Tada

I agree 300-500mil is a low-ball #. I am reading between the lines based on slide 17 from the Zenith AGM - see below circled in  red: "very low valuation - discounted". Based on annual projected sales of ZEN-3694 of 1.5bil and where they are in the approval process the price would have to be steeply discounted. The point is to get the cash now to fund the BOM2 and Covid trials for RVX with minimal dilution to get this show back on the road. This strategy does work if they can pull it off. ZCC would retain an 8% royalty on ZEN-3694 + the RVX royalty preferred shares.

Based on the limited info available from RVX and Zenith right now this is anybody's guess.

Chicagoest